Literature DB >> 11477267

Standardized perfusion value: universal CT contrast enhancement scale that correlates with FDG PET in lung nodules.

K A Miles1, M R Griffiths, M A Fuentes.   

Abstract

The standardized enhancement value and standardized perfusion value allow comparison between different methods for quantification of contrast enhancement during computed tomography (CT). Standard perfusion values calculated from CT measurements of perfusion within pulmonary nodules compared favorably with those derived from previously reported enhancement data and correlated with standardized uptake values obtained from positron emission tomographic images (r = 0.8, P <.01).

Mesh：

Substances：

Year:  2001        PMID： 11477267     DOI： 10.1148/radiology.220.2.r01au26548

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  30 in total

Review 1.  Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities.

Authors:  Wouter van Elmpt; Catharina M L Zegers; Marco Das; Dirk De Ruysscher
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Perfusion CT for head and neck tumors: pilot study.

Authors:  Zoran Rumboldt; Riyadh Al-Okaili; John P Deveikis
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

3.  Quantitative contrast-enhanced computed tomography: is there a need for system calibration?

Authors:  Kenneth A Miles; Helen Young; Sandra L Chica; Peter D Esser
Journal:  Eur Radiol       Date:  2006-09-29       Impact factor: 5.315

4.  Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography.

Authors:  Mai-Lin Chen; Qing-Yu Zeng; Jian-Wei Huo; Xiao-Ming Yin; Bao-Ping Li; Jian-Xin Liu
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

Review 5.  Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.

Authors:  Michael Ingrisch; Steven Sourbron
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-06       Impact factor: 2.745

6.  Use of patient outcome endpoints to identify the best functional CT imaging parameters in metastatic renal cell carcinoma patients.

Authors:  Jill Rachel Mains; Frede Donskov; Erik Morre Pedersen; Hans Henrik Torp Madsen; Jesper Thygesen; Kennet Thorup; Finn Rasmussen
Journal:  Br J Radiol       Date:  2018-01-02       Impact factor: 3.039

7.  Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography.

Authors:  K A Miles; M R Griffiths; C J Keith
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-23       Impact factor: 9.236

8.  The Use of CT Perfusion to Determine Microvessel Density in Lung Cancer: Comparison with FDG-PET and Pathology.

Authors:  Ning Xing; Zu-Long Cai; Shao-Hong Zhao; Li Yang; Bai-Xuan Xu; Fu-Lin Wang
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

9.  Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target.

Authors:  Paolo Farace; Daniela D'Ambrosio; Flavia Merigo; Mirco Galiè; Cristina Nanni; Antonello Spinelli; Stefano Fanti; Anna Degrassi; Andrea Sbarbati; Domenico Rubello; Pasquina Marzola
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-18       Impact factor: 9.236

10.  Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis.

Authors:  Yuki Hattori; Toshifumi Gabata; Osamu Matsui; Kentaro Mochizuki; Hirohisa Kitagawa; Masato Kayahara; Tetsuo Ohta; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.